The research highlights the role of immune checkpoint inhibitors, drugs that enhance the body's ability to fight tumors.
For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study published in Cell Reports ...
Ike Onwere, MD: It is [sometimes] based on giving the FOLFOX [leucovorin, fluorouracil, and oxaliplatin] every 2 weeks. It’s ...
The FDA approved perioperative durvalumab (Imfinzi) in combination with a multidrug chemotherapy regimen for resectable ...
Dr. Robert Fortuna led a study at UR Medicine and authored a report that prompts physicians to suggest lung cancer screenings ...
A 75-year-old man with non-small cell lung cancer shows radiologic enlargement after neoadjuvant therapy; however, ...
1d
'I didn't think I would be here this year': Stage 4 lung cancer patient shares message to community
According to the CDC, more people across the country die from lung cancer compared to any other type of cancer. It's often ...
Researchers reveal that current lung cancer screening guidelines miss 65% of patients, and call for universal age-based ...
Two teams discover how small cell lung cancer hijacks neural pathways to proliferate faster, especially to the brain. Common ...
The lung cancer screening system “is not a risk assessment. It is a judgment system designed as one,” writes the director of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback